Literature DB >> 27456556

Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.

Maria Sambade1, Allison Deal1, Allison Schorzman1,2, J Christopher Luft1, Charles Bowerman1,3, Kevin Chu1,2, Olga Karginova1,4, Amanda Van Swearingen1, William Zamboni1,2, Joseph DeSimone1,3, Carey K Anders1,4.   

Abstract

AIM: Particle Replication in Nonwetting Templates (PRINT(®)) PLGA nanoparticles of docetaxel and acid-labile C2-dimethyl-Si-Docetaxel were evaluated with small molecule docetaxel as treatments for non-small-cell lung cancer brain metastases. MATERIALS &
METHODS: Pharmacokinetics, survival, tumor growth and mice weight change were efficacy measures against intracranial A549 tumors in nude mice. Treatments were administered by intravenous injection.
RESULTS: Intracranial tumor concentrations of PRINT-docetaxel and PRINT-C2-docetaxel were 13- and sevenfold greater, respectively, than SM-docetaxel. C2-docetaxel conversion to docetaxel was threefold higher in intracranial tumor as compared with nontumor tissues. PRINT-C2-docetaxel increased median survival by 35% with less toxicity as compared with other treatments.
CONCLUSION: The decreased toxicity of the PRINT-C2-docetaxel improved treatment efficacy against non-small-cell lung cancer brain metastasis.

Entities:  

Keywords:  Particle Replication in Non-wetting Templates (PRINT)® PLGA nanoparticle; acid-labile docetaxel prodrug; blood–brain barrier

Mesh:

Substances:

Year:  2016        PMID: 27456556      PMCID: PMC4996152          DOI: 10.2217/nnm-2016-0147

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  22 in total

1.  The effect of particle design on cellular internalization pathways.

Authors:  Stephanie E A Gratton; Patricia A Ropp; Patrick D Pohlhaus; J Christopher Luft; Victoria J Madden; Mary E Napier; Joseph M DeSimone
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

Review 2.  Current approaches to the treatment of metastatic brain tumours.

Authors:  Taofeek K Owonikoko; Jack Arbiser; Amelia Zelnak; Hui-Kuo G Shu; Hyunsuk Shim; Adam M Robin; Steven N Kalkanis; Timothy G Whitsett; Bodour Salhia; Nhan L Tran; Timothy Ryken; Michael K Moore; Kathleen M Egan; Jeffrey J Olson
Journal:  Nat Rev Clin Oncol       Date:  2014-02-25       Impact factor: 66.675

3.  Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.

Authors:  Olga Karginova; Marni B Siegel; Amanda E D Van Swearingen; Allison M Deal; Barbara Adamo; Maria J Sambade; Soha Bazyar; Nana Nikolaishvili-Feinberg; Ryan Bash; Sara O'Neal; Katie Sandison; Joel S Parker; Charlene Santos; David Darr; William Zamboni; Yueh Z Lee; C Ryan Miller; Carey K Anders
Journal:  Mol Cancer Ther       Date:  2015-04       Impact factor: 6.261

4.  Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.

Authors:  Mark D Walsh; Suzan K Hanna; Jeremy Sen; Sumit Rawal; Carolina B Cabral; Alex V Yurkovetskiy; Robert J Fram; Timothy B Lowinger; William C Zamboni
Journal:  Clin Cancer Res       Date:  2012-03-05       Impact factor: 12.531

5.  Incorporation and controlled release of silyl ether prodrugs from PRINT nanoparticles.

Authors:  Matthew C Parrott; Mathew Finniss; J Chris Luft; Ashish Pandya; Anuradha Gullapalli; Mary E Napier; Joseph M DeSimone
Journal:  J Am Chem Soc       Date:  2012-04-30       Impact factor: 15.419

Review 6.  The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era.

Authors:  Zarnie Lwin; Jonathan W Riess; David Gandara
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 7.  Stimuli-responsive nanoparticles for targeting the tumor microenvironment.

Authors:  Jinzhi Du; Lucas A Lane; Shuming Nie
Journal:  J Control Release       Date:  2015-09-01       Impact factor: 9.776

Review 8.  Management of non-small-cell lung cancer: recent developments.

Authors:  Martin Reck; David F Heigener; Tony Mok; Jean-Charles Soria; Klaus F Rabe
Journal:  Lancet       Date:  2013-08-24       Impact factor: 79.321

9.  Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.

Authors:  Carey K Anders; Barbara Adamo; Olga Karginova; Allison M Deal; Sumit Rawal; David Darr; Allison Schorzman; Charlene Santos; Ryan Bash; Tal Kafri; Lisa Carey; C Ryan Miller; Charles M Perou; Norman Sharpless; William C Zamboni
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

10.  Selective permeabilization of the blood-brain barrier at sites of metastasis.

Authors:  John J Connell; Grégoire Chatain; Bart Cornelissen; Katherine A Vallis; Alastair Hamilton; Len Seymour; Daniel C Anthony; Nicola R Sibson
Journal:  J Natl Cancer Inst       Date:  2013-10-09       Impact factor: 13.506

View more
  4 in total

1.  Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.

Authors:  Afroz S Mohammad; Jessica I Griffith; Chris E Adkins; Neal Shah; Emily Sechrest; Emma L Dolan; Tori B Terrell-Hall; Bart S Hendriks; Helen Lee; Paul R Lockman
Journal:  Pharm Res       Date:  2018-01-09       Impact factor: 4.200

2.  Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.

Authors:  Amanda E D Van Swearingen; Maria J Sambade; Marni B Siegel; Shivani Sud; Robert S McNeill; Samantha M Bevill; Xin Chen; Ryan E Bash; Louisa Mounsey; Brian T Golitz; Charlene Santos; Allison Deal; Joel S Parker; Naim Rashid; C Ryan Miller; Gary L Johnson; Carey K Anders
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

Review 3.  MicroRNA delivery through nanoparticles.

Authors:  Sharon Wei Ling Lee; Camilla Paoletti; Marco Campisi; Tatsuya Osaki; Giulia Adriani; Roger D Kamm; Clara Mattu; Valeria Chiono
Journal:  J Control Release       Date:  2019-10-14       Impact factor: 9.776

Review 4.  Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines.

Authors:  Manuel Valiente; Amanda E D Van Swearingen; Carey K Anders; Amos Bairoch; Adrienne Boire; Paula D Bos; Diana M Cittelly; Neta Erez; Gino B Ferraro; Dai Fukumura; Brunilde Gril; Meenhard Herlyn; Sheri L Holmen; Rakesh K Jain; Johanna A Joyce; Mihaela Lorger; Joan Massague; Josh Neman; Nicola R Sibson; Patricia S Steeg; Frits Thorsen; Leonie S Young; Damir Varešlija; Adina Vultur; Frances Weis-Garcia; Frank Winkler
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.